Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.
<iframe src="https://statesidedaily.com/embed/cluster/841bf2a3fb52460802d98cd7bf0b01c841d4e6f9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Indian Drugmaker Taps Private Credit for Japanese Acquisition"></iframe>